Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co
NYSE:BMY
Price:
43.99 USD
0.66%
Market Closed
Updated:
May 4, 2024
Bristol-Myers Squibb Co
Operating Expenses
|
Bristol-Myers Squibb Co
Operating Expenses Peer Comparison
Comparables:
JNJ
PFE
MRK
ZTS
LLY
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Operating Expenses
-$24.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-11%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Operating Expenses
-$35.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-1%
|
|
|
Pfizer Inc
NYSE:PFE
|
Operating Expenses
-$28.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-2%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Operating Expenses
-$39.8B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-8%
|
|
|
Zoetis Inc
NYSE:ZTS
|
Operating Expenses
-$2.9B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-4%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Operating Expenses
-$17.5B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-4%
|
See Also
What is Bristol-Myers Squibb Co's Operating Expenses?
Operating Expenses
-24.1B
USD
-24.1B
USD
Based on the financial report for Mar 31, 2024, Bristol-Myers Squibb Co's Operating Expenses amounts to -24.1B USD.
What is Bristol-Myers Squibb Co's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-11%
-11%
Over the last year, the Operating Expenses growth was 1%. The average annual Operating Expenses growth rates for Bristol-Myers Squibb Co have been 2% over the past three years , -23% over the past five years , and -11% over the past ten years .
You don't have any saved screeners yet
